Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
4.520
-0.170 (-3.62%)
At close: Dec 20, 2024, 4:00 PM
4.600
+0.080 (1.77%)
After-hours: Dec 20, 2024, 6:06 PM EST
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $87.33 million as of December 20, 2024. Its market cap has decreased by -40.28% in one year.
Market Cap
87.33M
Enterprise Value
70.16M
1-Year Change
-40.28%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $87.33M, an increase of 50.56%. That is a compound annual growth rate of 15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 87.33M | -39.57% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentek | 89.78M |
| HilleVax | 89.72M |
| LENSAR | 89.43M |
| Monogram Technologies | 88.53M |
| Coya Therapeutics | 87.55M |
| Anixa Biosciences | 86.56M |
| Fractyl Health | 86.10M |
| ALX Oncology Holdings | 85.44M |